What is the Concerta (methylphenidate) dose equivalent for Lisdexamfetamine (Vyvanse) 40mg once daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The approximate Concerta (methylphenidate) dose equivalent for Vyvanse (lisdexamfetamine) 40mg once daily is about 36-54mg of Concerta once daily. When converting between these medications, it's essential to understand that they are different stimulant classes - Vyvanse is an amphetamine-based medication while Concerta is methylphenidate-based. This conversion is not exact because the medications work differently in the body and individual responses vary significantly. Vyvanse 40mg is considered a moderate dose, so starting with Concerta 36mg and adjusting based on clinical response would be reasonable. The conversion should be supervised by a healthcare provider who can monitor for effectiveness and side effects. Patients should be aware that even at equivalent doses, they may experience different effects or side effects when switching between these medications due to their distinct mechanisms of action. The transition between medications typically requires careful titration and monitoring rather than an immediate complete switch.

Some key points to consider when making this conversion include:

  • The study by 1 compared the effects of lisdexamfetamine and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents, providing insight into the comparative efficacy of these medications.
  • The dosing and efficacy of Concerta have been evaluated in several studies, including those by 2, 3, and 4, which provide information on its pharmacokinetic profile and effectiveness in managing ADHD symptoms.
  • A review of OROS methylphenidate (Concerta) by 5 highlights its role in the treatment of ADHD, including its benefits and considerations for use.

Given the information available, the recommended approach is to start with a lower dose of Concerta, such as 36mg, and adjust as needed based on clinical response, while closely monitoring for both efficacy and side effects 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.